Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113420883 | 11342088 | 3 | F | 2011 | 20160812 | 20150805 | 20160823 | EXP | DK-JNJFOC-20150721650 | JANSSEN | 64.70 | YR | A | M | Y | 0.00000 | 20160823 | MD | DK | DK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113420883 | 11342088 | 1 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | APPROXIMATELY TOTAL NUMBER OF INFUSIONS: 5. | Y | N | 0 | 300 | MG | LYOPHILIZED POWDER | |||||
| 113420883 | 11342088 | 2 | PS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | Y | N | 103772 | LYOPHILIZED POWDER | ||||||||
| 113420883 | 11342088 | 3 | SS | METHOTREXATE. | METHOTREXATE | 1 | Oral | Y | 0 | 7.5 | MG | TABLET | /wk | ||||||
| 113420883 | 11342088 | 4 | C | PERSANTIN | DIPYRIDAMOLE | 1 | Oral | 0 | 200 | MG | PROLONGED-RELEASE CAPSULE | BID | |||||||
| 113420883 | 11342088 | 5 | C | SIFROL | PRAMIPEXOLE | 1 | Oral | 0 | .088 | MG | TABLET | QD | |||||||
| 113420883 | 11342088 | 6 | C | ACETYLSALICYLIC ACID | ASPIRIN | 1 | Oral | 0 | 75 | MG | TABLET | QD | |||||||
| 113420883 | 11342088 | 7 | C | FOLIMET | 2 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 113420883 | 11342088 | 1 | Hidradenitis |
| 113420883 | 11342088 | 2 | Hidradenitis |
| 113420883 | 11342088 | 3 | Hidradenitis |
| 113420883 | 11342088 | 4 | Thrombosis prophylaxis |
| 113420883 | 11342088 | 5 | Restless legs syndrome |
| 113420883 | 11342088 | 6 | Thrombosis prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 113420883 | 11342088 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 113420883 | 11342088 | Alveolitis allergic | |
| 113420883 | 11342088 | Diarrhoea | |
| 113420883 | 11342088 | Off label use | |
| 113420883 | 11342088 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 113420883 | 11342088 | 1 | 20140825 | 20150316 | 0 | |
| 113420883 | 11342088 | 2 | 2011 | 2014 | 0 | |
| 113420883 | 11342088 | 3 | 20140825 | 20150511 | 0 |